In pancreatic cancer, dysregulated metabolic pathways are critical for tumor growth and survival and SIRT5 may contribute to the adaptation of cancer cells to the nutrient-deprived tumor microenvironment [115]. This evidence concerns the gene SIRT5 and familial pancreatic carcinoma.